Gonococcal resistance: are cephalosporins next? (Q37848735)

24 August 2017

title

Gonococcal resistance: are cephalosporins next? (English)

1 reference

24 August 2017

Robert D Kirkcaldy

1

1 reference

24 August 2017

Ronald C Ballard

series ordinal

2

1 reference

24 August 2017

Deborah Dowell

series ordinal

3

1 reference

24 August 2017

publication date

1 April 2011

1 reference

Current infectious disease reports

24 August 2017

published in

1 reference

24 August 2017

volume

13

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

196-204

1 reference

From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Antibiotic resistance in Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Antimicrobial resistance pattern of Neisseria gonorrhoeae isolates from peripheral health centres and STD clinic attendees of a tertiary care centre in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

European surveillance of antimicrobial resistance in Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Characteristics and population dynamics of mosaic penA allele-containing Neisseria gonorrhoeae isolates collected in Sydney, Australia, in 2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Rapid detection of the mosaic structure of the Neisseria gonorrhoeae penA Gene, which is associated with decreased susceptibilities to oral cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Update on the management of gonorrhea in adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Gentamicin in gonococcal urethritis of Filipino males: dosage and response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Pharyngeal gonorrhoea - is dual therapy the way forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0169-9

Gentamicin in the treatment of infections due to penicillinase-producing gonococci

21 January 2018

1 reference

12 December 2020

Treatment of gonorrhoea with single injections of gentamicin

1 reference

12 December 2020

Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.

1 reference

12 December 2020

Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcal urethritis in Zambia.

1 reference

12 December 2020

Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan

1 reference

12 December 2020

Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.

1 reference

12 December 2020

STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation.

1 reference

12 December 2020

Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006

1 reference

12 December 2020

The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--national resistance prevalence in 2007 and 2008, and trends during 2005-2008.

1 reference

12 December 2020

Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.

1 reference

12 December 2020

Gentamicin in the treatment of gonococcal urethritis. A microbiological, pharmacological, and clinical study

1 reference

12 December 2020

Threat to cefixime treatment for gonorrhea

1 reference

12 December 2020

Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods

1 reference

12 December 2020

Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections

1 reference

12 December 2020

Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian regions, 2007-2008.

1 reference

12 December 2020

Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.

1 reference

12 December 2020

10.1007/S11908-011-0169-9

Identifiers

DOI

1 reference

24 August 2017

1 reference